top of page

ARIScience is RESHAPING THE FUTURE OF DRUG DISCOVERY

Identifying new cures for societal diseases through AI and Quantum Chemistry (AI+QQ) 

Our novel in-silico platform unites AI, quantum chemistry, computer vision and bio-chemistry (AI+QQ) to design and discover molecule compounds that interrupt disease pathways.

 

Assessed via established in vitro and in vivo assays, these small molecule compounds interrupt proteins allosterically, directly or formatively.

 

We are purusing treatments for prevalent neurodegenerative, inflammatory and infectious diseases by focusing on the interruption of aberrant, overexpressed or pathogenic proteins.

drive_hhs_logo-removebg-preview.png

We are thrilled to announce that we've been awarded an advanced protein impact via small molecule research contract by the United States Biomedical Advanced Research and Development Agency in April of 2023.

Bleeding-Edge Technology

Interrupt Proteins Like Never Before

Our novel in silico quasi quantum calculation methodology combined with a unique computation-first approach and diverse, purpose-driven team of experts delivers unparalleled results. Merging traditionally disparate scientific disciplines and utilizing cutting-edge technology and methodologies allows us to efficiently iterate and refine drug candidates, leading to higher success rates and a faster time-to-societal-impact for our clients. Our leading approach and expertise have resulted in a proven track record of success, and we are dedicated to bringing advanced science driven therapeutics to patients.

pexels-edward-jenner-4031322.jpg
DALL_E_2023-04-26_09.37.10_-_viral_protein_bound_to_a_small_molecule_drug-removebg-preview

Drug Discovery Process

Learn how our unique drug discovery process to addresses the burden of disease on society. For more detailed information click here.

Drug Discovery

1

Predict and construct organic compounds that can directly or allosterically interrupt proteins in biological pathways using in silico methodology.

2

Confirm in silico results through in vitro assays.

3

Iterate and optimize compounds using derivative molecules based on in vitro results.

4

Confirm results through in vivo small animal models, typically murine models.

5

Candidate drugs are taken to FIH trials in in vivo test results are positive.

DALL_E_2023-04-26_09.38.10_-_viral_protein_bound_to_a_small_molecule-removebg-preview.png

Get in Touch

Interested in our services? Have a question for the team? Reach out to us.

Thanks for submitting!

bottom of page